Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2007; 13(23): 3221-3227
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3221
Table 2 Relationship between AR and ER Immunostaining values and Clinico-Pathological Characteristics
CharacteristicsAndrogen receptors (AR)
Estrogen receptors (ER)
n (%)Score valuesmedian (range)n (%)Score valuesmedian (range)
Males18 (69.2)4.1 (0-229.5)12 (46.2)8.5 (0-65)
Age < 65 yr15 (71.4)6.7 (0-52)10 (47.6)8.5 (0-65)
Cirrhosis19 (65.5)4.2 (0-229.5)16 (55.2)8.5 (0-65)
VHC (+)11 (68.8)4.2 (0-229.5)11 (68.8)8.75 (0-65)
Alcohol etiology7 (53.8)3.7 (0-52)3 (23.1)0 (0-65)
Uninodular16 (64)4.2 (0-229.5)13 (52)8.5 (0-65)
Tumor size
< median13 (61.9)4 (0-229.5)12 (57.1)8.5 (0-65)
≥ median8 (80)5.75 (0-16)4 (40)8.7 (0-15.75)
Alfa-fetoprotein (ng/mL)
< 2012 (63.2)4 (0-229.5)8 (42.1)8.5 (0-65)
≥ 209 (75)5.7 (0-31)8 (66.7)8.7 (0-16)
Histopathology
HCC-T20 (71.4)4.5 (0-229.5)15 (53.6)8.5 (0-65)
Non HCC-T1 (33.3)1 (0-26.25)1 (33.3)0 (0-20.5)
Death
No11 (84.6)12 (0-229.5)6 (46.2)9 (0-65)
Yes10 (55.6)4 (0-28.75)10 (55.6)8.5 (0-20.5)
Androgen receptors
Negative--3 (30)0 (0-20.5)a
Positive13 (61.9)9 (0-65)
Estrogen receptors
Negative8 (53.3)3.2 (0-29)--
Positive13 (81.3)8.4 (0-229.5)
Progesterone receptors
Negative0 (0)c1.7 (0-4.2)a1 (20)0 (0-8.5)a
Positive21 (80.8)8.4 (0-229.5)15 (57.7)9 (0-65)
Apo D
Negative13 (68.4)4.2 (0-52)10 (52.6)8.5 (0-65)
Positive8 (66.7)4.2 (0-229.5)6 (50)8.5 (0-65)